Effects of tetrandrine and closely related bis-benzylisoquinoline derivatives on cytosolic Ca2+ in human leukaemic HL-60 cells: A structure-activity relationship study

Clinical and Experimental Pharmacology and Physiology

Volumn 23, Issue 8, 1996, Pages 653-659

  Leung, Yuk Man ^a   Berdik, Mariana ^a   Kwan, Chiu Yin ^a   Loh, Tatt Tuck ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Berbamine; Calcium entry; Hernandezine; HL 60 cells; Plant alkaloids; Tetrandrine; Thapsigargin

Indexed keywords

BERBAMINE; BISBENZYLISOQUINOLINE ALKALOID; HERNANDESINE; ISOQUINOLINE DERIVATIVE; TETRANDRINE; THAPSIGARGIN;

ARTICLE; CALCIUM METABOLISM; CALCIUM TRANSPORT; CHEMICAL STRUCTURE; HUMAN; HUMAN CELL; LEUKEMIA CELL; STRUCTURE ACTIVITY RELATION;

EID: 0029852444     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1996.tb01752.x     Document Type: Article

References (30)

1. 2+ influx following receptor activation. Trends Pharmacol. Sci. 1991; 12: 289-92.
2. Felder CC, Singer-Lahat D, Mathes C. Voltage-independent calcium channels. Regulation by receptors and intracellular calcium stores. Biochem. Pharmacol. 1994; 48: 1997-2004.
3. Putney JW Jr. Capacitative calcium entry revisited. Cell Calcium 1990; 11: 611-24.
4. 2+ influx: How many mechanisms for how many channels? Trends Pharmacol. Sci. 1994; 15: 77-83.
5. 2+ ATPase. Proc. Natl Acad. Sci. USA 1990; 87: 2466-70.
6. Lytton J, Westlin M, Hanley MR. Thapsigargin inhibits the sarcoplasmic or endoplasmic reticulum Ca-ATPase family of calcium pumps. J. Biol. Chem. 1991; 266: 17067-71.
7. 2+ pump inhibitor of rat aortic muscle. Acta Pharmacol. Sin. 1991; 12: 53-8.
8. 2+ stores and activates an influx pathway for divalent cations in HL-60 cells. J. Biol. Chem. 1992; 267: 2318-24.
9. 2+ influx at the plasma membrane: Voltage-, receptor-, and second messenger-operated channels. Exp. Cell. Res. 1987; 171: 271-83.
10. 2++ antagonist: Effects and mechanisms of action in vascular smooth muscle cells. J. Pharmacol. Exp. Ther. 1995; 273: 32-9.
11. Kwan CY, Deng HW, Guan YY. Tetrandine is not a selective calcium channel blocker in vascular smooth muscle. Acta Pharmacol. Sin. 1992; 13: 385-90.
12. Ma LJ, Yin ZZ, Liu GZ. Effect of hernandezine on platelet aggregation and its mechanism of action. Chin. J. Pharmacol. Toxicol. 1991; 5: 41-3.
13. 2+ influx of pig basilar artery. Acta Pharmacol. Sin. 1993; 13: 412-16.
14. Leung YM, Kwan CY, Loh TT. Dual effects of tetrandrine on cytosolic calcium in human leukaemic HL-60 cells: Intracellular calcium release and calcium entry blockade. Br. J. Pharmacol. 1994; 113: 767-74.
15. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 1985; 260: 3440-50.
16. 2+ transport by smooth muscle microsomes: Revisitation of the old problem by a new approach using saponin. Biochim. Biophys. Acta 1985; 819: 148-52.
17. King VF, Garcia ML, Himmel D et al. Interaction of tetrandrine with slowly inactivating calcium channels. Characterization of calcium channel modulation by an alkaloid of Chinese medicinal herb origin. J. Biol. Chem. 1988; 263: 2238-44.
18. Felix JP, King VF, Shevell JL et al. Bis(benzylisoquinoline) analogs of tetrandrine block L-type calcium channels: Evidence for interaction at the diltiazem-binding site. Biochemistry 1992; 31: 11793-800.
19. Liu QY, Karpinski E, Rao MR, Pang PKT. Tetrandrine: A novel calcium channel antagonist inhibits type I calcium channels in neuroblastoma cells. Neuropharmacology 1991; 30: 1325-31.
20. Liu QY, Karpinski E, Pang PKT. Tetrandrine inhibits both T and L calcium channel currents in ventricular cells. J. Cardiovasc. Pharmacol. 1992; 20: 513-19.
21. Rossier MF, Python CP, Capponi AM, Schlegel W, Kwan CY, Vallotton MB. Blocking T-type calcium channels with tetrandrine inhibits steroidogenesis in bovine adrenal glomerulosa cells. Endocrinology 1993; 132: 1035-43.
22. 2+ current in isolated nerve terminals of the rat neurohypophysis. Pflügers Arch. 1992; 421: 558-65.
23. 2+ channels. Life Sci. 1995; 56: 295-306.
24. Schiff PL Jr. Bisbenzylisoquinoline alkaloids. J. Nat. Prod. 1991; 54: 645-9.
25. 2 in rabbit platelets. Biochem. Pharmacol. 1991; 41: 419-23.
26. Li SY, Ling LH, Teh BS, Scow WK, Thong YH. Anti-inflammatory and immunosuppressive properties of the bis-benzylisoquinolines: In vitro comparisons of tetrandrine and berbamine. Int. J. Immunopharmacol. 1989; 11: 395-401.
27. Teh BS, Seow WK, Li SY, Thong YH. Inhibition of prostaglandin and leukotriene generation by the plant alkaloids tetrandrine and berbamine. Int. J. Immunopharmacol. 1990; 12: 321-6.
28. Seow WK, Ferrante A, Summers A, Thong YH. Comparative effects of tetrandrine and berbamine on production of the inflammatory cytokines interleukin-1 and tumor necrosis factor. Life Sci. 1992; 50: PL53-8.
29. Whitehouse MW, Fairlie DP, Thong YH. Anti-inflammatory activity of the isoquinoline alkaloid, tetrandrine, against established adjuvant arthritis in rats. Agents Actions 1994; 42: 123-7.
30. Su JY. Mechanisms of action of 7-O-ethyl tetrandrine in isolated vascular smooth muscle of the rabbit aorta. Naunyn-Schmiedeberg's Arch. Pharmacol. 1993; 347: 445-51.